Showing results (571-580 of 1,007) with videos related to

Sort By:
Pageof 101
Thrombosis Journal|August 24, 2006
Soluble fibrin inhibits monocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasisJohn P Biggerstaff, Brandy Weidow, Jacqueline Vidosh, et al.
Thrombosis Journal|November 30, 2022
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implicationsLorenzo Loffredo, Gianpaolo Vidili, Angela Sciacqua, et al.
Thrombosis Journal|June 27, 2022
Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategyYang-Chao Zhao, Xi Zhao, Guo-Wei Fu, et al.
Thrombosis Journal|December 15, 2022
Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)Sara El-Sayed Abd El-Ghani, Reham Mohammad Raafat Hamed, Ragaey Ahmad Eid, et al.
Thrombosis Journal|May 25, 2022
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flowWei Yin, Andrew Dimatteo, Andrew Kumpfbeck, et al.
Thrombosis Journal|April 17, 2019
Correction to: Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani populationArshi Naz, Arijit Biswas, Tehmina Nafees Khan, et al.
Thrombosis Journal|August 7, 2018
Decreased antithrombin activity in the early phase of trauma is strongly associated with extravascular leakage, but not with antithrombin consumption: a prospective observational studyHironori Matsumoto, Jun Takeba, Kensuke Umakoshi, et al.
Thrombosis Journal|May 12, 2017
The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV)Davide Imberti, Marco Marietta, Hernan Polo Friz, et al.
Thrombosis Journal|April 29, 2017
Reduced cardiac function and risk of venous thromboembolism in Asian countriesRuiqi Zhu, Yu Hu, Liang Tang
Thrombosis Journal|May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Pageof 101